LIVN
LivaNova PLC

379
Mkt Cap
$3.81B
Volume
2M
52W High
$69.52
52W Low
$32.48
PE Ratio
-17.22
LIVN Fundamentals
Price
$70.29
Prev Close
$69.05
Open
$64.16
50D MA
$64.27
Beta
0.90
Avg. Volume
589,128.70
EPS (Annual)
$1.16
P/B
3.26
Rev/Employee
$432,219.66
$2,480.54
Loading...
Loading...

Earnings Recap

• Reported GAAP EPS of $0.57 down -44.66% YoY • Reported revenue of $360.9M up 12.15% YoY • LivaNova PLC expects full-year 2026 revenue to grow 6.0% to 7.0% on a constant-currency basis. Adjusted diluted earnings per share is projected between $4.15 and $4.25, with adjusted free cash flow in the $160 million to $180 million range.

Bullish

LivaNova PLC secured increased VNS Therapy reimbursement and FDA approval for its digital health platform. The company also achieved double-digit reported and organic revenue growth with continued operating margin expansion for full-year 2025.

Bearish

LivaNova PLC faced a full-year 2025 U.S. GAAP diluted loss per share of $4.45 due to a $365.6M environmental liability. The company also experienced a significant Q4 GAAP EPS decline and a substantial decrease in Other Revenue.

Latest LIVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.